関連する実験動画
Updated: May 3, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.2K
併発性肺線維症と肺がん: 更新された説明レビュー
Bartłomiej Czyżak1, Sebastian Majewski1
1Department of Pneumology, Medical University of Lodz, 90-153 Lodz, Poland.
Advances in respiratory medicine
|August 27, 2025
まとめ
Idiopathic pulmonary fibrosis (IPF) と肺がん (LC) は共通する経路を持っています. 抗線維薬は,IPF患者のLCに対する保護を提供することができ,潜在的な新しい治療戦略を強調します.
科学分野:
- 肺科
- 腫瘍学
- 翻訳医学
背景:
- Idiopathic pulmonary fibrosis (IPF) は,治療法が限られている進行中の間隔性肺疾患である.
- 抗線維薬はIPFの生存率を改善し,肺がん (LC) などの併発症の認識を高めました.
- IPFとLCの相互作用を理解することは,患者の管理に不可欠です.
研究 の 目的:
- IPF患者におけるLCの疫学と病原性を検討する.
- 分子,細胞,遺伝,および表遺伝的変異の共有を調査する.
- 抗線維薬の急性悪化と潜在的な保護効果を含む診断と治療上の課題について議論する.
主な方法:
- IPF と LC に関する研究の包括的な文献レビュー.
- 共通の病理学的メカニズムを分析する.
- 現在の診断と治療戦略の評価
主要な成果:
- IPFとLCは共通の分子,細胞,遺伝的経路を共有しています.
- IPF-LCの診断と治療方法は,特に急性悪化に関して限られています.
- 新しい証拠は,抗線維薬がIPFにおけるLCのリスクを減らす可能性があることを示唆しています.
結論:
- IPFとLCの共通のメカニズムは,新しい治療目標のためのさらなる調査を正当化します.
- IPF-LC患者のケアを最適化するには,多学科的な臨床ガイドラインが不可欠です.
- 抗線維薬は,IPF患者のLC発症を予防する可能性があることを示しています.
関連する概念動画
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:08Pneumothorax II: Pathophysiology
55
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance...
55
01:10Atelectasis II: Pathophysiology
40
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
40
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40